Search

Your search keyword '"Nurieva, Roza"' showing total 356 results
Start Over Author "Nurieva, Roza" Publication Year Range Last 50 years
356 results on '"Nurieva, Roza"'

1. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Author

Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, and Nurieva, Roza

Published
2022
Full Text
View/download PDF

2. Toxicity in the era of immune checkpoint inhibitor therapy.

Author

Keam, Synat, Turner, Naimah, Kugeratski, Fernanda G., Rico, Rene, Colunga-Minutti, Jocelynn, Poojary, Rayansh, Alekseev, Sayan, Patel, Anisha B., Li, Yuanteng Jeff, Sheshadri, Ajay, Loghin, Monica E., Woodman, Karin, Aaroe, Ashley E., Hamidi, Sarah, Iyer, Priyanka Chandrasekhar, Palaskas, Nicolas L., Yinghong Wang, and Nurieva, Roza

Subjects
IMMUNE checkpoint proteins, CYTOTOXIC T cells, IMMUNE checkpoint inhibitors, ANIMAL models in research, PROGRAMMED cell death 1 receptors
Abstract

Immune checkpoint inhibitors (ICIs) reinvigorate anti-tumor immune responses by disrupting co-inhibitory immune checkpoint molecules such as programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4). Although ICIs have had unprecedented success and have become the standard of care for many cancers, they are often accompanied by off-target inflammation that can occur in any organ system. These immune related adverse events (irAEs) often require steroid use and/or cessation of ICI therapy, which can both lead to cancer progression. Although irAEs are common, the detailed molecular and immune mechanisms underlying their development are still elusive. To further our understanding of irAEs and develop effective treatment options, there is pressing need for preclinical models recapitulating the clinical settings. In this review, we describe current preclinical models and immune implications of ICI-induced skin toxicities, colitis, neurological and endocrine toxicities, pneumonitis, arthritis, and myocarditis along with their management. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics

Author

Lu, Lina, Wang, Jennifer Rui, Henderson, Ying C., Bai, Shanshan, Yang, Jie, Hu, Min, Shiau, Cheng-Kai, Pan, Timothy, Yan, Yuanqing, Tran, Tuan M., Li, Jianzhuo, Kieser, Rachel, Zhao, Xiao, Wang, Jiping, Nurieva, Roza, Williams, Michelle D., Cabanillas, Maria E., Dadu, Ramona, Busaidy, Naifa Lamki, Zafereo, Mark, Navin, Nicholas, Lai, Stephen Y., and Gao, Ruli

Subjects
Thyroid cancer -- Development and progression -- Genetic aspects, Genetic transcription -- Health aspects, Cell transformation -- Genetic aspects -- Health aspects, Health care industry
Abstract

The deadliest anaplastic thyroid cancer (ATC) often transforms from indolent differentiated thyroid cancer (DTC); however, the complex intratumor transformation process is poorly understood. We investigated an anaplastic transformation model by dissecting both cell lineage and cell fate transitions using single-cell transcriptomic and genetic alteration data from patients with different subtypes of thyroid cancer. The resulting spectrum of ATC transformation included stress-responsive DTC cells, inflammatory ATC cells (iATCs), and mitotic-defective ATC cells and extended all the way to mesenchymal ATC cells (mATCs). Furthermore, our analysis identified 2 important milestones: (a) a diploid stage, in which iATC cells were diploids with inflammatory phenotypes and (b) an aneuploid stage, in which mATCs gained aneuploid genomes and mesenchymal phenotypes, producing excessive amounts of collagen and collagen-interacting receptors. In parallel, cancer- associated fibroblasts showed strong interactions among mesenchymal cell types, macrophages shifted from M1 to M2 states, and T cells reprogrammed from cytotoxic to exhausted states, highlighting new therapeutic opportunities for the treatment of ATC., Introduction Anaplastic thyroid cancer (ATC), characterized by an undifferentiated morphology, is arguably one of the most lethal malignancies. According to Surveillance, Epidemiology and End Results (SEER) data (released April 2021) [...]

Published
2023
Full Text
View/download PDF

5. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy

Author

Turner, Naimah, primary, Hamidi, Sarah, additional, Ouni, Rim, additional, Rico, Rene, additional, Henderson, Ying C., additional, Puche, Maria, additional, Alekseev, Sayan, additional, Colunga-Minutti, Jocelynn G., additional, Zafereo, Mark E., additional, Lai, Stephen Y., additional, Kim, Sang T., additional, Cabanillas, Maria E., additional, and Nurieva, Roza, additional

Published
2024
Full Text
View/download PDF

7. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction

Author

Liu, Xindong, Wang, Yun, Lu, Huiping, Li, Jing, Yan, Xiaowei, Xiao, Minglu, Hao, Jing, Alekseev, Andrei, Khong, Hiep, Chen, Tenghui, Huang, Rui, Wu, Jin, Zhao, Qiwen, Wu, Qi, Xu, Senlin, Wang, Xiaohu, Jin, Wei, Yu, Shicang, Wang, Yan, Wei, Lai, Wang, Aibo, Zhong, Bo, Ni, Ling, Liu, Xiaolong, Nurieva, Roza, Ye, Lilin, Tian, Qiang, Bian, Xiu-Wu, and Dong, Chen

Published
2019
Full Text
View/download PDF

9. Abstract 3131: Anaplastic transformation model in thyroid cancer revealed by single cell lineage and fate analysis

Author

Lu, Lina, primary, Wang, Jennifer Rui, additional, Henderson, Ying C., additional, Bai, Shanshan, additional, Yang, Jie, additional, Hu, Min, additional, Yan, Yuanqing, additional, Tran, Tuan M, additional, Li, Jianzhuo, additional, Shiau, Cheng-Kai, additional, Kieser, Rachel, additional, Zhao, Xiao, additional, Wang, Jiping, additional, Nurieva, Roza, additional, Williams, Michelle D., additional, Cabanillas, Maria E., additional, Dadu, Ramona, additional, Busaidy, Naifa Lamki, additional, Zafereo, Mark, additional, Navin, Nicholas, additional, Lai, Stephen Y., additional, and Gao, Ruli, additional

Published
2023
Full Text
View/download PDF

10. Data from IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties

Author

Khosravi, Nasim, primary, Caetano, Mauricio S., primary, Cumpian, Amber M., primary, Unver, Nese, primary, De la Garza Ramos, Cynthia, primary, Noble, Oscar, primary, Daliri, Soudabeh, primary, Hernandez, Belinda J., primary, Gutierrez, Berenice A., primary, Evans, Scott E., primary, Hanash, Samir, primary, Alekseev, Andrei M., primary, Yang, Yi, primary, Chang, Seon Hee, primary, Nurieva, Roza, primary, Kadara, Humam, primary, Chen, Jichao, primary, Ostrin, Edwin J., primary, and Moghaddam, Seyed Javad, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figures and Table from IL22 Promotes Kras-Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties

Author

Khosravi, Nasim, primary, Caetano, Mauricio S., primary, Cumpian, Amber M., primary, Unver, Nese, primary, De la Garza Ramos, Cynthia, primary, Noble, Oscar, primary, Daliri, Soudabeh, primary, Hernandez, Belinda J., primary, Gutierrez, Berenice A., primary, Evans, Scott E., primary, Hanash, Samir, primary, Alekseev, Andrei M., primary, Yang, Yi, primary, Chang, Seon Hee, primary, Nurieva, Roza, primary, Kadara, Humam, primary, Chen, Jichao, primary, Ostrin, Edwin J., primary, and Moghaddam, Seyed Javad, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 5 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table 1 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Figure 2 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 5 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table 2 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Table 3 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Table 4 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

19. Movie 1 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

20. Movie 2 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 4 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure 3 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 1 from Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter

Author

Ritthipichai, Krit, primary, Haymaker, Cara L., primary, Martinez, Melisa, primary, Aschenbrenner, Andrew, primary, Yi, Xiaohui, primary, Zhang, Minying, primary, Kale, Charuta, primary, Vence, Luis M., primary, Roszik, Jason, primary, Hailemichael, Yared, primary, Overwijk, Willem W., primary, Varadarajan, Navin, primary, Nurieva, Roza, primary, Radvanyi, Laszlo G., primary, Hwu, Patrick, primary, and Bernatchez, Chantale, primary

Published
2023
Full Text
View/download PDF

28. Radiation therapy induces immunosenescence mediated by p90RSK

Author

Imanishi, Masaki, primary, Cheng, Haizi, additional, Kotla, Sivareddy, additional, Deswal, Anita, additional, Le, Nhat-Tu, additional, Chini, Eduardo, additional, Ko, Kyung Ae, additional, Samanthapudi, Venkata S. K., additional, Lee, Ling-Ling, additional, Herrmann, Joerg, additional, Xu, Xiaolei, additional, Reyes-Gibby, Cielito, additional, Yeung, Sai-Ching J., additional, Schadler, Keri L., additional, Yusuf, Syed Wamique, additional, Liao, Zhongxing, additional, Nurieva, Roza, additional, Amir, El-ad David, additional, Burks, Jared K., additional, Palaskas, Nicolas L., additional, Cooke, John P., additional, Lin, Steven H., additional, Kobayashi, Michihiro, additional, Yoshimoto, Momoko, additional, and Abe, Jun-ichi, additional

Published
2022
Full Text
View/download PDF

29. Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer

Author

Xu, Ting, primary, Wu, Lirong, additional, Gandhi, Saumil, additional, Jing, Wang, additional, Nguyen, Quyhn-Nhu, additional, Chen, Aileen, additional, Chang, Joe Y., additional, Nurieva, Roza, additional, Sheshadri, Ajay, additional, Altan, Mehmet, additional, Lee, Percy P., additional, Lin, Steven H., additional, and Liao, Zhongxing, additional

Published
2022
Full Text
View/download PDF

34. Abstract 503: Multiparameter Mass Cytometry Reveals The Unique Response Of NaïVe B Cell Cd27 - Subset With The Increase Of T-bet And Cd38 Expression After Radiation Therapy In Thoracic Cancer Patients

Author

Imanishi, Masaki, primary, Cheng, Haizi, additional, Kotla, Sivareddy, additional, Lin, Steven, additional, Deswal, Anita, additional, Ko, Kyung, additional, Samanthapudi, Venkatasubrahman, additional, Le, Nhat-Tu, additional, Fujiwara, Keigi, additional, Liao, Zhongxing, additional, Palaskas, Nicolas L, additional, Yusuf, Syed Wamique, additional, Nurieva, Roza I, additional, Reyes-Gibby, Cielito, additional, Yeung, Sai-Ching, additional, Amir, El-ad David, additional, Burks, Jared K, additional, Kobayashi, Michihiro, additional, Yoshimoto, Momoko, additional, and Abe, Jun-ichi, additional

Published
2022
Full Text
View/download PDF

35. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Author

Hailemichael, Yared, primary, Johnson, Daniel H., additional, Abdel-Wahab, Noha, additional, Foo, Wai Chin, additional, Bentebibel, Salah-Eddine, additional, Daher, May, additional, Haymaker, Cara, additional, Wani, Khalida, additional, Saberian, Chantal, additional, Ogata, Dai, additional, Kim, Sang T., additional, Nurieva, Roza, additional, Lazar, Alexander J., additional, Abu-Sbeih, Hamzah, additional, Fa'ak, Faisal, additional, Mathew, Antony, additional, Wang, Yinghong, additional, Falohun, Adewunmi, additional, Trinh, Van, additional, Zobniw, Chrystia, additional, Spillson, Christine, additional, Burks, Jared K., additional, Awiwi, Muhammad, additional, Elsayes, Khaled, additional, Soto, Luisa Solis, additional, Melendez, Brenda D., additional, Davies, Michael A., additional, Wargo, Jennifer, additional, Curry, Jonathan, additional, Yee, Cassian, additional, Lizee, Gregory, additional, Singh, Shalini, additional, Sharma, Padmanee, additional, Allison, James P., additional, Hwu, Patrick, additional, Ekmekcioglu, Suhendan, additional, and Diab, Adi, additional

Published
2022
Full Text
View/download PDF

37. Characterization of Altered immunity in Anaplastic Thyroid Cancer

Author

Ouni, Rim, primary, Henderson, Ying, additional, Chen, Yunyun, additional, Turner, Naimah, additional, Padron, William, additional, Dadbin, Ali, additional, McBeath Fujiwara, Elena, additional, Wang, Jennifer R., additional, Cabanillas, Maria, additional, Dadu, Romana, additional, Hofmann, Marie-Claude, additional, Zafereo, Mark E., additional, Kim, Sang Taek, additional, Lai, Stephen, additional, and Nurieva, Roza, additional

Published
2022
Full Text
View/download PDF

38. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice

Author

Qin, Hong, Lerman, Beatrisa, Sakamaki, Ippei, Wei, Guowei, Cha, Soungchul C., Rao, Sheetal S., Qian, Jianfei, Hailemichael, Yared, Nurieva, Roza, Dwyer, Karen C., Roth, Johannes, Yi, Qing, Overwijk, Willem W., and Kwak, Larry W.

Subjects
Tumors -- Analysis -- Health aspects -- Development and progression -- Genetic aspects -- Care and treatment -- Research, Immune response -- Physiological aspects -- Genetic aspects -- Research, Peptides -- Analysis -- Health aspects -- Physiological aspects -- Genetic aspects -- Research, Biological sciences, Health
Abstract

Immune evasion is an emerging hallmark of cancer progression. However, functional studies to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment are limited by the lack of available specific cell surface markers. We adapted a competitive peptide phage display platform to identify candidate peptides binding MDSCs specifically and generated peptide-Fc fusion proteins (peptibodies). In multiple tumor models, intravenous peptibody injection completely depleted blood, splenic and intratumoral MDSCs in tumor-bearing mice without affecting proinflammatory immune cell types, such as dendritic cells. Whereas control Gr-1-specific antibody primarily depleted granulocytic MDSCs, peptibodies depleted both granulocytic and monocytic MDSC subsets. Peptibody treatment was associated with inhibition of tumor growth in vivo, which was superior to that achieved with Gr-1-specific antibody. Immunoprecipitation of MDSC membrane proteins identified S100 family proteins as candidate targets. Our strategy may be useful to identify new diagnostic and therapeutic surface targets on rare cell subtypes, including human MDSCs., Activating the immune system has emerged as a promising way to treat cancer. Recent successful phase 3 clinical trials of therapeutic cancer vaccines include the US Food and Drug Administration-approved [...]

Published
2014
Full Text
View/download PDF

39. Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development

Author

Liu, Xindong, Chen, Xin, Zhong, Bo, Wang, Aibo, Wang, Xiaohu, Chu, Fuliang, Nurieva, Roza I., Yan, Xiaowei, Chen, Ping, van der Flier, Laurens G., Nakatsukasa, Hiroko, Neelapu, Sattva S., Chen, Wanjun, Clevers, Hans, Tian, Qiang, Qi, Hai, Wei, Lai, and Dong, Chen

Subjects
T cells -- Genetic aspects, Cell development (Biology) -- Genetic aspects, Transcription factors -- Identification and classification, Environmental issues, Science and technology, Zoology and wildlife conservation
Abstract

In immune responses, activated T cells migrate to B-cell follicles and develop into follicular T-helper ([T.sub.FH]) cells, a recently identified subset of [CD4.sup.+] T cells specialized in providing help to B lymphocytes in the induction of germinal centres (1,2). Although Bcl6 has been shown to be essential in [T.sub.FH]-cell function, it may not regulate the initial migration of T cells (3) or the induction of the [T.sub.FH] program, as exemplified by C-X-C chemokine receptor type 5 (CXCR5) upregulation (4). Here we show that expression of achaete-scute homologue 2 (Ascl2)--a basic helix-loop-helix (bHLH) transcription factor (5)--is selectively upregulated in [T.sub.FH] cells. Ectopic expression of Ascl2 upregulates CXCR5 but not Bcl6, and downregulates C-C chemokine receptor 7 (CCR7) expression in T cells in vitro, as well as accelerating T-cell migration to the follicles and [T.sub.FH]-cell development in vivo in mice. Genome-wide analysis indicates that Ascl2 directly regulates [T.sub.FH]-related genes whereas it inhibits expression of T-helper cell 1 ([T.sub.H]1) and [T.sub.H]17 signature genes. Acute deletion of Ascl2, as well as blockade of its function with the Id3 protein in [CD4.sup.+] T cells, results in impaired [T.sub.FH]-cell development and germinal centre response. Conversely, mutation of Id3, known to cause antibody-mediated autoimmunity, greatly enhances [T.sub.FH]-cell generation. Thus, Ascl2 directly initiates [T.sub.FH]-cell development., The development of [T.sub.FH] cells is initiated by and dependent on their movement out of the T-cell zone and into the B-cell follicle. This migration process is regulated by upregulation [...]

Published
2014

41. Follicular regulatory T cells expressing foxp3 and Bcl-6 suppress germinal center reactions

Author

Chung, Yeonseok, Tanaka, Shinya, Chu, Fuliang, Nurieva, Roza I., Martinez, Gustavo J., Rawal, Seema, Wang, Yi-Hong, Lim, Hoyong, Reynolds, Joseph M., Zhou, Xiao-hui, Fan, Hui-min, Liu, Zhong-ming, Neelapu, Sattva S., and Dong, Chen

Subjects
Gene expression -- Research, T cells -- Physiological aspects -- Research, Immune response -- Research, Polymerase chain reaction -- Usage, Biological sciences, Health
Abstract

[Foxp3.sup.+] regulatory T ([T.sub.reg]) cells suppress different types of immune responses to help maintain homeostasis in the body. How [T.sub.reg] cells regulate humoral immunity, including germinal center reactions, is unclear. Here we identify a subset of [T.sub.reg] cells expressing CXCR5 and Bcl-6 that localize to the germinal centers in mice and humans. The expression of CXCR5 on [T.sub.reg] cells depends on Bcl-6. These [CXCR5.sup.+][Bcl-6.sup.+] [T.sub.reg] cells are absent in the thymus but can be generated de novo from CXCR5-[Foxp3.sup.+] natural [T.sub.reg] precursors. A lack of CXCR5+ [T.sub.reg] cells leads to greater germinal center reactions including germinal center B cells, affinity maturation of antibodies and the differentiation of plasma cells. These results unveil a Bcl-6-CXCR5 axis in [T.sub.reg] cells that drives the development of follicular regulatory T ([T.sub.FR]) cells that function to inhibit the germinal center reactions., The vertebrate immune system contains a unique subset of T cells expressing Foxp3 that prevent autoimmunity against self antigens and exaggerated immune responses. Deficiency of Foxp3 in humans results in [...]

Published
2011
Full Text
View/download PDF

46. Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications

Author

Kim, Sang T., primary, Sheshadri, Ajay, additional, Shannon, Vickie, additional, Kontoyiannis, Dimitrios P., additional, Kantarjian, Hagop, additional, Garcia-Manero, Guillermo, additional, Ravandi, Farhad, additional, Im, Jin S., additional, Boddu, Prajwal, additional, Bashoura, Lara, additional, Balachandran, Diwakar D., additional, Evans, Scott E., additional, Faiz, Saadia, additional, Ruiz Vazquez, Wilfredo, additional, Divenko, Margarita, additional, Mathur, Rohit, additional, Tippen, Samantha P., additional, Gumbs, Curtis, additional, Neelapu, Sattva S., additional, Naing, Aung, additional, Wang, Linghua, additional, Diab, Adi, additional, Futreal, Andrew, additional, Nurieva, Roza, additional, and Daver, Naval, additional

Published
2021
Full Text
View/download PDF

47. Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity

Author

Hailemichael, Yared, primary, Johnson, Daniel H., additional, Abdel-Wahab, Noha, additional, Foo, Wai Chin, additional, Daher, May, additional, Haymaker, Cara, additional, Wani, Khalida M., additional, Saberian, Chantal M., additional, Ogata, Dai, additional, Bentebibel, Salah Eddine, additional, Kim, Sang Taek, additional, Nurieva, Roza, additional, Lazar, Alexander, additional, Abu-Sbeih, Hamzah, additional, Wang, Yinghong, additional, Trinh, Van Anh, additional, Zobniw, Chrystia M., additional, Spillson, Christine A., additional, Burks, Jared K., additional, Solis, Luisa, additional, Francisco Cruz, Alejandro, additional, Marques-Piubelli, Mario Luiz, additional, Lu, Wei, additional, Melendez, Brenda Denisse, additional, Davies, Michael A., additional, Wargo, Jennifer, additional, Curry, Jonathan L., additional, Lizee, Gregory A., additional, Yee, Cassian, additional, Hwu, Patrick, additional, Ekmekcioglu, Suhendan, additional, and Diab, Adi, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results